You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 17, November 4, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Infectious Diseases, Other
 •Immunization
 •Public Health, Other
 •H1N1 Influenza
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Influenza in 2009

New Solutions, Same Old Problems

Julie Louise Gerberding, MD, MPH

JAMA. 2009;302(17):1907-1908.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 1941, the Commission on Influenza of the Armed Forces Epidemiological Board (AFEB) established a comprehensive national research plan to address the most important unanswered scientific questions about influenza.1 The commission prioritized assessment of vaccine and immune serum prophylaxis efficacy but also defined a much broader scope of collaborative work across the academic, public health, and military sectors. The plan included evaluation of isolation and quarantine practices, environmental controls, and the effectiveness of masks to control infection; field studies to define the clinical, microbiologic, pathologic, and epidemiologic correlates of infection and disease for specific virus subtypes; and evaluation of treatment regimens, including prophylaxis for bacterial superinfections.

As clinicians and public health practitioners contend with the 2009 influenza A(H1N1) virus pandemic, the health care community should be grateful to the commission for accurately anticipating the requirements for effective control and for pioneering the investigations that ultimately . . . [Full Text of this Article]

Author Affiliation: Former director, Centers for Disease Control and Prevention, Atlanta, Georgia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.